RenovaCare Announces Management Changes
Scottsdale, AZ – March 24, 2022 – RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), clinical-stage developer of patented cell therapy technologies for the regeneration of skin and tissues, today announced reductions in its management team to further streamline administrative expenses.